Clinical Trials Directory

Trials / Completed

CompletedNCT04534569

Expert Panel Statement for the Respiratory Management of COVID-19 Related Acute Respiratory Failure (C-ARF)

Expert Panel Statement for the Respiratory Management of COVID-19 Related Acute Respiratory Failure (C-ARF) Using Modified Delphi Methodology

Status
Completed
Phase
Study type
Observational
Enrollment
40 (actual)
Sponsor
NMC Specialty Hospital · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The investigators aim to achieve experts consensus on respiratory interventions in management of COVID-19 related acute respiratory failure (C-ARF).

Detailed description

The investigators aim to achieve experts consensus on respiratory interventions in management of COVID-19 related acute respiratory failure (C-ARF). The pandemic of COVID-19 is unique in terms of a multitude of patients suffering from ARF and requiring invasive mechanical ventilation with single underlying inciting etiology.The experts have given divergent opinions on respiratory support of C-ARF which may have confused physicians globally. The investigators are going to use a modified Delphi based methodology involving global participating experts. The objective is to achieve consensus statement on the management of C-ARF using "collective intelligence". The whole process of this study will be done in the form of two-three rounds of Google Forms-based Delphi surveys. In this survey questionnaire, the investigators have prepared statements on the concern areas in the respiratory support of C-ARF. The survey has been divided into five sections related to C-ARF management. The majority of these statements are to be rated on Likert scale and others have multiple choices. There is an option for collecting participating experts comments in provided open space in round one which will be considered during round two questionnaire.

Conditions

Interventions

TypeNameDescription
OTHERExperts consensusConsensus opinion using Delphi Methodology

Timeline

Start date
2020-09-04
Primary completion
2020-10-03
Completion
2020-10-06
First posted
2020-09-01
Last updated
2020-10-08

Locations

1 site across 1 country: United Arab Emirates

Source: ClinicalTrials.gov record NCT04534569. Inclusion in this directory is not an endorsement.